期刊文献+

产吲哚金黄杆菌56株临床分布及耐药性分析 被引量:4

原文传递
导出
摘要 目的研究南京大学医学院附属鼓楼医院产吲哚金黄杆菌医院感染的分布及耐药性,为临床治疗提供参考。方法收集该院2006-01-2008-12临床分离的产吲哚黄杆菌共56株,采用ATB Expression细菌鉴定仪鉴定,药敏试验采用K-B纸片扩散法检测产吲哚金黄杆菌对12种抗菌药物的敏感性。结果产吲哚性金黄杆菌在各类标本中痰液的分离频率最高,为62.5%;产吲哚性金黄杆菌由重症监护病房送检标本分离率最高,为32.1%。产吲哚黄杆菌对多种抗菌药物耐药,对米诺环素和复方新诺明耐药率较低,分别为12.5%、0%。结论产吲哚黄杆菌是一种高度耐药的细菌,治疗上应根据药敏选用抗菌药物。
作者 姚晓娟
出处 《中国误诊学杂志》 CAS 2010年第30期7554-7555,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献5

二级参考文献17

  • 1董晓勤,周田美,施新颜,吴盛海,范建中,汪涛.非发酵菌感染的临床分布和耐药谱分析[J].中华医院感染学杂志,2004,14(7):809-811. 被引量:47
  • 2董云秋,张晓炜,孔宪玺.36株脑膜脓毒金黄杆菌体外抗菌活性分析[J].中华医院感染学杂志,2006,16(1):96-98. 被引量:9
  • 3于兰.黄杆菌属细菌院内感染的护理对策分析[J].临床和实验医学杂志,2007,6(3):193-193. 被引量:1
  • 4National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial testing[S]. Eleventh information supplement. NCCLS Doucuments,2006.40.108.
  • 5Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening rnetallo-β-1actamase-producing Gram-negative bacteria by using thiol compounds[J].J Clin Microbiol,2000, 38(1) :40-43.
  • 6Jeffrey T,Kirby HS,Sader TR,etal. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001)[J]. J Clin Microbiol, 2004,42(1) : 445-448.
  • 7Chen GX,Zhang R,Zhou HW. Heterogeneity of metallo-beta-lactamases in clinical isolates of Chryseobacterium meningosepticum from Hangzhou, China[J]. J Antimierob Chemother, 2006,57 (4) : 750-752.
  • 8National Committee for Clinical Laboratory Standards. Performance standards for antimierobial testing[S]. Eleventh information supplement. NCCLS,2002.78.
  • 9Bellais S, Naas T, Nordmann P. Genetic and biochemical characterization of CGB-1, an ambler class B carbapenem-hydrolyzing beta-lactamase from Chryseobacterium gleum[J]. Antimicrob Agents Chemother, 2002,46(9): 2791-2796.
  • 10Bellais S,Poirel L,Leotard S,et al.Genetic diversity of carbarpennem hydrolyzing metallo lactamase from chryseobacterium (flavobacterium)[J].Antimicrob Agents che mother,2000,44:3028 ~ 3034.

共引文献27

同被引文献30

  • 1Moorthy RK, Rajshekhar V. Management of brain abscess: an overview?. Neurosurg Focus, 2008, 24 (6) : E3.
  • 2Hakan T. Management of bacterial brain abscesses. Neurosurg Focus,2008,24(6) : FA.
  • 3Calder6n G, Garcta E, Rojas P, et al. Chryseobacterium indologenes infection in a newborn: a case report. J Med Case Reports,2011, 14(5) :10.
  • 4Hsueh PR, Teng LJ, Yang PC, et al. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis, 1997,16 (8) :568-574.
  • 5Chou DW, Wu SL, Lee CT antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit. Jpn J Infect Dis ,2011,64 (6) :520-524.
  • 6Kocherry XG, Hegde T, Sastry K, et ai. Efficacy of stereotaetlc aspiration in deep-seated and eloquent-region intracranial pyogenic abscesses. Neurosurg Focus, 2008,24(6) : E13.
  • 7Bhuyar G, Jain S, Shah H, et al. Urinary tract infection by Chryseobacterium indologenes [J]. Indian J Med Microbiol, 2012,30(3) :370.
  • 8Sudharani V, Asiya, Saxena N K. Chryseobacterium indotogenes bacteraemia in a preterm baby [J].Indian J Med Microbiol, 2011,29(2) :196.
  • 9Hendaus MA, Zahraldin K. Chryseobacterium indologenes menin- gitis in a healthy newborn:a case report[J].Oman Med J ,2013, 28(2) :133.
  • 10Lin YT, Jeng YY, Lin ML, et al. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia[J]. J Mierobiol Immunol Infect,2010,43(6):498.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部